Indexed with PubMed and Science Citation Index (E)
Users online:
3832
Home
|
Feedback
|
Reader Login
About
Current Issue
Archive
Ahead of print
Search
Instructions
Online Submission
Subscribe
What's New
Contact
NAVIGATE
here
Search
Current Issue
Submit Article
My Preferences
Dermatology crossword
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
Access statistics : Table of Contents
2019| May-June | Volume 85 | Issue 3
Online since
April 19, 2019
Archives
Previous Issue
Next Issue
Most popular articles
Most cited articles
Show all abstracts
Show selected abstracts
Export selected to
Viewed
PDF
Cited
REVIEW ARTICLE
Hidradenitis Suppurativa: A Systematic Review and Meta-analysis of Therapeutic Interventions
Huidi Tchero, Christian Herlin, Farid Bekara, Sergiu Fluieraru, Luc Teot
May-June 2019, 85(3):248-257
DOI
:10.4103/ijdvl.IJDVL_69_18
PMID
:30924446
Hidradenitis suppurativa is a chronic inflammatory condition that affects skin regions bearing apocrine glands. Although hidradenitis suppurativa is difficult to treat and cure, the currently available treatments are directed toward managing the lesions and associated symptoms. This review presents an evidence-based outline of the available treatment options. We searched four electronic databases and extracted data from retrieved studies for qualitative or quantitative analysis. Meta-analysis was conducted using the comprehensive meta-analysis software to generate pooled standardized mean differences or risk ratios. Numerous medical treatments are available for hidradenitis suppurativa such as antibiotics, retinoids, antiandrogens, immunosuppressive and anti-inflammatory agents and radiotherapy for early lesions. Adalimumab, an anti-tumor necrosis factor antibody, was superior to placebo in reducing Sartorius score (standardized mean difference = −0.32, confidence interval [−0.46, −0.18],
P
< 0.0001) and pain (risk ratio = 1.42, confidence interval [1.07, 1.9],
P
= 0.02), when given weekly (not every other week). Combination therapies (such as antibiotics and hyperbaric oxygen therapy) have been tested, which have shown promising results that are yet to be confirmed. Based on the quality of evidence, the most recommended treatments for hidradenitis suppurativa include adalimumab and laser therapy. Surgery (either by simple excision or complete local excision followed by skin graft) is the first choice for intractable disease presenting in the late stages. However, the evidence on most of these treatments is deficient and further randomized trials are needed to establish the most efficient therapies for hidradenitis suppurativa management.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
7,243
460
-
ORIGINAL ARTICLES
A randomized, double-blind trial of amorolfine 0.25% cream and sertaconazole 2% cream in limited dermatophytosis
Anirban Das, Amrita Sil, Tushar Kanti Sarkar, Arpita Sen, Sriparna Chakravorty, Manideepa Sengupta, Anupam Das, Somodyuti Chandra, Santasmita Pal, Debabrata Bandyopadhyay, Nilay Kanti Das
May-June 2019, 85(3):276-281
DOI
:10.4103/ijdvl.IJDVL_907_17
PMID
:30409926
Background:
Dermatophytosis is becoming increasingly unresponsive to conventional antifungals. Newer topical antifungals may be more effective in these patients.
Aims:
To evaluate and compare the efficacy and safety of amorolfine 0.25% cream and sertaconazole 2% cream in limited tinea cruris/corporis.
Methods:
A single-center, randomized (1:1), double-blind, parallel group, active-controlled trial (CTRI/2014/12/005246) was performed. Sixty-six untreated adults with acutely symptomatic tinea cruris/corporis were included in the study. All patients had limited cutaneous involvement and were KOH mount positive. Group A received amorolfine 0.25% cream, and group B received sertaconazole 2% cream twice daily application to the lesions for 4 weeks. After the baseline visit, four follow-up visits were carried out. The outcome measures for effectiveness were clinical and mycological cure. Safety parameters studied were treatment-emergent adverse events and changes in routine laboratory parameters.
Results:
Both sertaconazole and amorolfine significantly reduced symptoms (
P
< 0.001) in both groups. However, improvement in symptoms (pruritus, burning sensation, erythema, scaling and crusting) was significantly greater in the sertaconazole group at every follow-up visit. Sertaconazole cream was also more effective than amorolfine cream in reducing the number of lesions (
P
= 0.002 at 12 weeks) and improving the Dermatology Life Quality Index (
P
< 0.001) at all the follow-up visits. Adverse events were similar in the two groups (
P
= 0.117). Fungal cultures became negative in 92.3% of the sertaconazole group as compared to 80% in the amorolfine group (
P
= 0.010).
Limitations:
Antifungal susceptibility testing could not be done.
Conclusion:
Sertaconazole 2% is superior to amorolfine 0.25%, both in terms of effectiveness and tolerability. Improvement can be appreciated from second week onwards.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
5,587
361
-
RESIDENTS’ PAGE
Atopy patch test
Varsha Vaidyanathan, Aarti Sarda, Abhishek De, Sandipan Dhar
May-June 2019, 85(3):338-341
DOI
:10.4103/ijdvl.IJDVL_397_17
PMID
:30058560
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
3,482
378
-
ORIGINAL ARTICLES
Does using a high sun protection factor sunscreen on face, along with physical photoprotection advice, in patients with melasma, change serum vitamin D concentration in Indian conditions? A pragmatic pretest-posttest study
Sanjay Singh, Bandana Jha, Narendra Kumar Tiwary, Neeraj Kumar Agrawal
May-June 2019, 85(3):282-286
DOI
:10.4103/ijdvl.IJDVL_575_17
PMID
:30409925
Background:
Use of sunscreens on the face is becoming popular, and patients with melasma are prescribed sunscreen for use on the face. Results of a few Western studies on the effect of sunscreen use on serum vitamin D concentration are not applicable to Indian conditions.
Aims:
To examine the effect of use of a high sun protection factor (SPF 50+, PA++++) sunscreen on face in patients with melasma on serum concentration of 25-hydroxyvitamin D.
Methods:
Forty-five Indian patients (Fitzpatrick skin types III and IV) with melasma were advised to use a sunscreen with SPF 50 + for 3 months, 43 (33 female, 10 male; age 32.9 ± 8 years) completed the study. Patients staying outdoor for <4 hours applied sunscreen once daily after bath. Patients staying outdoors for >4 hours reapplied sunscreen 4 hours after first application. Patients were provided a container to measure the amount of sunscreen for use, which was approximately equal to recommended thickness. Compliance was tested by weighing the used tubes and tubes in use during monthly visits. Serum concentration of 25-hydroxyvitamin D was tested before and after the study period.
Results:
Amount of sunscreen advised (100.5 ± 29.2 ml) and the actual amount used (96.6 ± 27.9 ml) were similar (
P
= 0.53,
t
-test). The difference between serum concentrations of 25-hydroxyvitamin D at the baseline (19.20 ± 9.06 ng/ml) and at 3 months (18.91 ± 8.39 ng/ml) was not significant (
P
= 0.87, paired
t
-test, 95% confidence interval of difference −3.33 to 3.92). No correlation was found between the amount of sunscreen used and the percentage change in serum 25-hydroxyvitamin D concentration at 3 months (rho = 0.099,
P
= 0.528, Spearman's rank correlation).
Limitations:
Longer duration of application and a larger sample size may detect minor differences in vitamin D concentration.
Conclusion:
Using a high SPF sunscreen on the face, along with physical photoprotection advice, in patients with melasma for 3 months does not influence serum 25-hydroxyvitamin D concentration in Indian conditions.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
3,557
226
-
VIEW POINT
Let's not let the guard down! – Early indications of syphilis resurgence?
Vinay Kulkarni, Ritu Parchure, Shrinivas Darak
May-June 2019, 85(3):246-247
DOI
:10.4103/ijdvl.IJDVL_728_17
PMID
:30829295
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
3,497
197
-
LETTERS TO THE EDITOR - CASE LETTER
Acral peeling skin syndrome: An underdiagnosed skin disorder
Eva Sticova, Martin Květoň, Monika Dubská, Andrea Kubátová
May-June 2019, 85(3):316-318
DOI
:10.4103/ijdvl.IJDVL_3_18
PMID
:30688214
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
3,471
117
-
ORIGINAL ARTICLES
Predictors of disease severity in drug reaction with eosinophilia and systemic symptoms
Sarita Sasidharanpillai, Anuradha Thalian Chathoth, Anza Khader, Olasseri K Reena Mariyath, Najeeba Riyaz, Manikoth Payyanadan Binitha, Kunnummal Muhammed, Biju George, Parvathy Santhosh, Sangeetha Roslind, Nina Paul, Mithun Harold Thomas
May-June 2019, 85(3):266-275
DOI
:10.4103/ijdvl.IJDVL_482_17
PMID
:30058562
Background:
Drug reaction with eosinophilia and systemic symptoms is an outcome of a complex interaction between specific drugs, certain herpesviruse types and the immune system of the affected individual and is characterized by an unpredictable course and recurrent flares even after withdrawal of the offending drug and administration of systemic steroids.
Aims:
To identify the predictors of disease severity in drug reaction with eosinophilia and systemic symptoms.
Methods:
After obtaining ethical clearance from the institutional ethics committee and a written informed consent from individual study participant, the first hundred patients who required inpatient care in Government Medical College, Kozhikode with drug reaction with eosinophilia and systemic symptoms from January 1
st
2011 were included in this study aimed to identify the predictors of disease severity in drug reaction with eosinophilia and systemic symptoms.
Results:
Male-to-female ratio of the study group was 0.8:1. The presence of atypical cells in peripheral smear and advanced age were found to be predictors of disease severity in drug reaction with eosinophilia and systemic symptoms, whereas, sex, facial erythema and edema and absolute eosinophil count were found not to be predictors of the same.
Limitations:
The main limitation of this study was our inability to assess the role of human leukocyte antigen (HLA) association and herpes virus reactivation in disease severity in drug reaction with eosinophilia and systemic symptoms. This study was also not designed to evaluate the response to treatment given and the mortality caused by drug reaction with eosinophilia and systemic symptoms.
Conclusions:
Studies on the predictors of severity in drug reaction with eosinophilia and systemic symptoms in different population groups may enable us to identify the warning signs and help to formulate the standard therapeutic guidelines.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
2,672
248
-
EDITORIAL
The peer review process: Yesterday, today and tomorrow
Saumya Panda
May-June 2019, 85(3):239-245
DOI
:10.4103/ijdvl.IJDVL_296_19
PMID
:30971533
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
2,457
112
-
ORIGINAL ARTICLES
Melanocyte spheroids are formed by repetitive long-term trypsinization
Di Li, Ru-Zhi Zhang, Hai-Xia Shi, Yu-Hua Yang, Ting Tian, Li Wang
May-June 2019, 85(3):258-265
DOI
:10.4103/ijdvl.IJDVL_275_17
PMID
:30785123
Background:
Autologous melanocyte transplantation plays an important role in the treatment of vitiligo.
Objective:
Previous studies have indicated that, compared with melanocytes growing in monolayers, melanocyte spheroids have a better survival in growth factor- and serum-deprived conditions.
Methods:
Melanocyte spheroids were obtained from human epidermis by repetitive long-term trypsinization and maintained an aggregated morphology for a short period in certain conditions.
Results:
Melanocyte spheroids were capable of growing into normal dendritic melanocytes in monolayer when they were harvested and reinoculated in 24-well plates. Immunohistochemical analysis of the melanocyte spheroids revealed that they were positive for HMB45, a melanosome-specific marker. No melanomas occurred when melanocyte spheroids were transplanted into mice.
Conclusion:
Our study provides a promising approach for melanocyte transplantation to treat vitiligo.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
2,245
104
-
QUIZ
Ringworm-like skin lesion is not always tinea
Ramona Zanniello, Caterina Ferreli, Federico Patta, Anna Luisa Pinna, Laura Atzori
May-June 2019, 85(3):335-337
DOI
:10.4103/ijdvl.IJDVL_253_17
PMID
:29547137
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
2,194
123
-
LETTERS TO THE EDITOR - OBSERVATION LETTERS
Dermoscopy combined with ink staining as one more method to diagnose nodular scabies
Yangyang Ma, Wenting Hu, Ping Wang, Ke Bian, Zehu Liu
May-June 2019, 85(3):324-325
DOI
:10.4103/ijdvl.IJDVL_516_18
PMID
:30880719
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
2,201
64
-
LETTERS TO THE EDITOR - LETTERS IN RESPONSE TO PREVIOUSLY PUBLISHED ARTICLES
Is semen analysis necessary prior to initiation of finasteride treatment?
Oliver Clement Lobo, Venkataram Mysore
May-June 2019, 85(3):310-311
DOI
:10.4103/ijdvl.IJDVL_149_19
PMID
:30971531
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
2,048
65
-
BOOK REVIEW
Dermoscopy – Text and atlas
Laxmisha Chandrashekar
May-June 2019, 85(3):346-346
DOI
:10.4103/ijdvl.IJDVL_108_19
PMID
:30950410
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
1,964
79
-
BRIEF REPORTS
Effect of low-dose acitretin treatment on pituitary hormones in psoriasis vulgaris: A retrospective study
Ayse Serap Karadag, Emin Ozlu, Osman Kostek, Serap Gunes Bilgili, Ragıp Balaharoglu, Derun Taner Ertugrul
May-June 2019, 85(3):300-304
DOI
:10.4103/ijdvl.IJDVL_628_17
PMID
:29855455
Background:
It has been reported that retinoids may lead to hormonal alterations.
Aim:
In this retrospective study, we aimed to study the effect of acitretin on pituitary hormones in psoriasis patients.
Methods:
Out of 50 patients intended to be studied, blood samples of 43 patients could be tested before and after 3 months of acitretin therapy (0.2 to 0.5 mg/kg/day).
Results:
Patients mean ± standard deviation ages and female/male ratio were 46 ± 17 years and 19/24, respectively. After treatment with acitretin, gamma-glutamyltransferase, alkaline phosphatase, total cholesterol and triglyceride levels increased significantly (
P
< 0.05). After treatment, total protein, free thyroxine (T4) levels decreased significantly (
P
< 0.05). No significant differences were observed between before–after acitretin treatment regarding pituitary hormone levels in psoriasis patients (
P
> 0.05).
Limitations:
The retrospective nature of the study, inability to retest blood samples of 7 patients at 3 months post treatment, low dose and short duration of acitretin treatment were limitations of this study.
Conclusion:
This study showed that pituitary hormones were not affected except free T4 (thyroid hormone) by acitretin treatment. Further experimental and clinical studies are needed to clarify the effect of acitretin on pituitary hormones.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
1,963
68
-
Serum and tissue angiotensin-converting enzyme in patients with alopecia areata
Shabnam Fahim, Fatemeh Montazer, Hamid Reza Tohidinik, Zahra Safaei Naraghi, Robabeh Abedini, Maryam Nasimi, Narges Ghandi
May-June 2019, 85(3):295-299
DOI
:10.4103/ijdvl.IJDVL_158_17
PMID
:29582789
Background:
Alopecia areata is an immune-dependent disorder characterized by the interaction of T-lymphocytes with follicular antigens. Recent studies have shown the existence of a local renin–angiotensin system in the skin, where angiotensin-converting enzyme (ACE) plays a role in autoimmunity and inflammation.
Aim:
The objective of this study was to evaluate serum and tissue ACE activity in patients with alopecia areata.
Methods:
This case–control study was conducted on patients with alopecia areata and healthy controls. Serum and tissue ACE activity were assessed and compared between the two groups.
Results:
Twenty-five alopecia areata patients (60% male, mean age 32.1 ± 9.9 years) and 24 controls (50% male, mean age 37.4 ± 8.8 years) were included. Mean serum ACE activity was 52.1 ± 9 U/L in cases and 55.3 ± 14.7 U/L in controls (
P
= 0.37). Tissue ACE activity was significantly lower in cases in all parts of the skin i.e. epidermis (
P
= 0.016), follicular epithelium (
P
= 0.004), and endothelium (
P
= 0.037). Among cases, serum ACE activity was significantly higher in patients with more severe disease (
P
= 0.030), nonpatchy alopecia areata (alopecia universalis; ophiasis, patchy and ophiasis, diffuse) (
P
= 0.029), and with nail involvement (
P
= 0.027).
Limitations:
The sample size was too small to draw definite conclusions. Further, most of the patients had only mild or moderate alopecia areata.
Conclusion:
Unlike in some other inflammatory diseases, the tissue level of ACE seems to be significantly lower in alopecia areata compared to normal controls. Serum ACE was significantly higher in patients with more severe disease.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
1,967
63
-
IMAGES IN CLINICAL PRACTICE
Primary follicular mucinosis in childhood
Parul Verma, Asha Kubba, Aditi Jha
May-June 2019, 85(3):333-334
DOI
:10.4103/ijdvl.IJDVL_615_17
PMID
:29697068
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
1,918
42
-
NET QUIZ
Erythematous scaly facial plaques with overlying hair loss
A Narayanan, M Ramam, Neetu Bhari
May-June 2019, 85(3):347-347
DOI
:10.4103/ijdvl.IJDVL_501_18
PMID
:30860166
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
1,879
76
-
NET LETTERS
Dermoscopic manifestations of
Talaromyces
(
Penicillium
)
marneffei
infection in an AIDS patient
Xiaoxi Xu, Xin Ran, Sushmita Pradhan, Song Lei, Yuping Ran
May-June 2019, 85(3):348-348
DOI
:10.4103/ijdvl.IJDVL_118_17
PMID
:29873309
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
1,798
41
-
NET STUDY
Profile of HIV serodiscordant couples in a tertiary care center
Srihari Sahana, Jayadev Betkerur
May-June 2019, 85(3):347-347
DOI
:10.4103/ijdvl.IJDVL_1101_16
PMID
:30860165
Background:
Globally, 36.7 million people are infected with Human Immunodeficiency Virus (HIV). Of these 36.7 million people, 2.1 million are in India. Integrated counseling and testing centers are the cornerstones of early access to prevention and support services. The term “serodiscordant couple” refers to a couple where one partner is HIV-positive and the other HIV-negative.
Aim:
To study the serodiscordance rates in a cohort of people attending integrated counseling and testing center.
Materials and Methods:
Aretrospective descriptive study of data from integrated counseling and testing center from January 2013 to December 2014 was done.
Results:
Of the 7489 persons tested, 306 persons were positive for HIV (192 males and 114 females) with a prevalence of 4 percent. Of the 126 couples tested, serodiscordance was found in 46 couples, while 80 couples were seroconcordant. The overall prevalence of HIV serodiscordance was 36.5 percent. Male positive and female negative couples (M+ F−) were 35 (76.0%) and female positive and male negative (F+ M−) were 11 (23.9%). Discordant M+ F− couples were significantly higher than discordant F+ M− couples (
P
< 0.001). Most participants were aged between 21 and 40 years. The average age of men was 41.91 years and that of women was 34.21 years. The average age difference between life partners was 7.7 years. Significant association was seen between age and gender, as females were found to be younger (
P
value = 0.001).
Limitation:
Information regarding years of married life, number of sex partners or sexual behavior pre- and post-detection were not collected. Thus, our data present only the magnitude of serodiscordance in a cohort but does not analyze the other predictors of serodiscordance.
Conclusion:
Serodiscordant relationships occur more commonly in India than is presumed. Our study highlights the profile of serodiscordant couples in this part of the country. Effective measures to prevent transmission of HIV within a serodiscordant relationship are necessary steps in halting the HIV epidemic.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
1,788
40
-
LETTERS TO THE EDITOR - OBSERVATION LETTERS
A case of hidroacanthoma simplex with new dermoscopic features
Roja Toosi, Kambiz Kamyab, Cliff Rosendahl, Soheil Tavakolpour, Maryam Daneshpazhooh, Hamidreza Mahmoudi
May-June 2019, 85(3):319-321
DOI
:10.4103/ijdvl.IJDVL_426_18
PMID
:30860169
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
1,801
25
-
QUIZ
Erythematous eroded plaque on the left nipple in a 75-year-old woman
Sergio Alvarez-Veliz, Paula Majluf-Caceres, Sergio González-Bombardiére
May-June 2019, 85(3):307-309
DOI
:10.4103/ijdvl.IJDVL_446_17
PMID
:30058561
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
1,678
78
-
LETTERS TO THE EDITOR - THERAPY LETTER
Aggressive erosive lichen planus associated with hepatitis C responding to sofosbuvir/ledipasvir treatment
Daniel Morgado-Carrasco, Andrea Combalia, Xavier Fustà-Novell, José Manuel Mascaró Jr, Pilar Iranzo
May-June 2019, 85(3):326-329
DOI
:10.4103/ijdvl.IJDVL_225_18
PMID
:30860163
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
1,656
37
-
IMAGES IN CLINICAL PRACTICE
Papillomatosis cutis lymphostatica
Sabah Bazouti, Siham Dikhaye, Nada Zizi
May-June 2019, 85(3):305-306
DOI
:10.4103/ijdvl.IJDVL_763_17
PMID
:29697069
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
1,625
63
-
CASE REPORTS
Cutaneous inflammation as a marker of malignant transformation in a patient with linear unilateral basaloid follicular hamartoma
Pablo Del Barrio-Diaz, Rodrigo Meza-Romero, Sergio González, Cristián Vera-Kellet
May-June 2019, 85(3):287-290
DOI
:10.4103/ijdvl.IJDVL_927_16
PMID
:30246704
Basaloid follicular hamartoma is a rare, benign and superficial malformation of hair follicles, characterized histologically by epithelial proliferation of basaloid cells with radial disposition. It can be mistaken for basal cell carcinoma. Even though these hamartomas are considered benign lesions, malignant transformation has rarely been reported. We report the case of a 45-year-old healthy woman, with linear, unilateral basaloid follicular hamartoma which developed inflamed papules histologically suggestive of basal cell carcinoma. We believe that identification of local inflammation could be a clinical clue to guide us towards a malignant transformation of basaloid follicular hamartoma.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
1,646
41
-
NET LETTERS
A case report of buffalopox: A zoonosis of concern
Ritu Gujarati, Siva Rami Reddy Karumuri, T Naresh Babu, B Janardhan
May-June 2019, 85(3):348-348
DOI
:10.4103/ijdvl.IJDVL_222_17
PMID
:29667609
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
1,615
57
-
CASE REPORTS
Synovial sarcoma complicating Maffucci syndrome
Rima Gammoudi, Amina Aounallah, Colandane Belajouza, Rafiaa Nouira
May-June 2019, 85(3):291-294
DOI
:10.4103/ijdvl.IJDVL_547_17
PMID
:29667613
Maffucci syndrome is a rare nonhereditary disorder comprising of lymphovascular malformations and multiple enchondromas, which may be associated with several internal malignancies. This report describes a new association of Maffucci syndrome with pedal synovial sarcoma. Our case is also remarkable as lymphangioma circumscriptum is the sole lymphovascular component, which has been rarely reported. The aim of this report is to generate awareness about this rare condition and also highlight the importance of screening for malignancies in this disorder.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
1,560
44
-
LETTERS TO THE EDITOR - STUDY LETTER
Does rapamycin induce melanin formation? An
in vitro
study assessing the effect of rapamycin on normal cultured melanocytes
Muthu Sendhil Kumaran, Niharika Srivastava, Keshavamurthy Vinay, Supriya Bhardwaj, Davinder Parsad
May-June 2019, 85(3):330-332
DOI
:10.4103/ijdvl.IJDVL_45_18
PMID
:30829293
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
1,521
28
-
LETTERS TO THE EDITOR - OBSERVATION LETTERS
Dermoscopic features of trichilemmal carcinoma
Zulkuf Arslan, Z Ulaş Bali, M Kürşat Evrenos, Peyker Temiz, Aylin Türel Ermertcan
May-June 2019, 85(3):321-323
DOI
:10.4103/ijdvl.IJDVL_468_18
PMID
:30860170
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
1,496
30
-
NET LETTERS
Rapid response of Kasabach–Meritt phenomenon to a combination of oral prednisolone and sirolimus
Sanjay Singh, Neetu Bhari, Snehal Agrawal, Kaushal K Verma
May-June 2019, 85(3):348-348
DOI
:10.4103/ijdvl.IJDVL_453_17
PMID
:29798936
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
1,451
44
-
LETTERS TO THE EDITOR - LETTERS IN RESPONSE TO PREVIOUSLY PUBLISHED ARTICLES
Authors' reply
Piyush Kumar, Anupam Das, Niharika Ranjan Lal, Sourabh Jain, Anupama Ghosh
May-June 2019, 85(3):311-313
DOI
:10.4103/ijdvl.IJDVL_245_19
PMID
:30971532
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
1,390
34
-
Transepidermal elimination: Role in leprosy transmission
Naveen Kumar Kansal
May-June 2019, 85(3):313-314
DOI
:10.4103/ijdvl.IJDVL_877_18
PMID
:30829298
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
1,295
56
-
Authors' reply
Hiral Shah, Anup Kumar Tiwary, Piyush Kumar
May-June 2019, 85(3):314-315
DOI
:10.4103/ijdvl.IJDVL_192_19
PMID
:30950408
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
1,090
24
-
HISTORY
Prof. Nékám's Corpus Iconum Morborum Cutaneorum (1938): The most elaborate historical dermatovenerological atlas of the first half of the 20
th
century
Zoltan Szep, Juraj Majtan
May-June 2019, 85(3):342-345
DOI
:10.4103/ijdvl.IJDVL_643_17
PMID
:30924445
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
893
24
-
ANNOUNCEMENT OF IADVL SCHOLARSHIPS
Announcement of IADVL Scholarships
May-June 2019, 85(3):350-350
DOI
:10.4103/0378-6323.256525
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
772
75
-
ERRATUM
Erratum: “Crusted nipple and areola: a new aetiology of secondary hyperkeratosis of the nipple and areola”
May-June 2019, 85(3):349-349
DOI
:10.4103/0378-6323.256524
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
637
35
-
Site Map
|
Contact Us
|
Feedback
|
Copyright and Disclaimer
Online since 15
th
March '04
Published by Wolters Kluwer -
Medknow